• Economic Evaluation of Breast Cancer Early Detection Strategies in Asia: A Systematic Review [Editor's Choice]

    May 1, 2020, 00:00

  • The Structure and Parameterization of the Breast Cancer Transition Model Among Chinese Women

    May 1, 2020, 00:00

  • Causes of Under-5 Mortality Among Brazil, the Russian Federation, India, China, and South Africa Nations: A Comparative Study

    May 1, 2020, 00:00

  • Drug Selection for Formulary Inclusion: An Exploratory Case Study of Oncology Medicines in Jordan

    May 1, 2020, 00:00

  • Cross-Cultural Adaptation and Psychometric Analysis of the Persian Version of the ICEpop CAPability Measure for Adults Capability Measure in the Iranian General Population

    May 1, 2020, 00:00

  • A Systematic Review of Equity in Healthcare Financing in Low- and Middle-Income Countries

    May 1, 2020, 00:00

  • Survey on Willingness to Pay for Life-Saving Treatment, Functional Recovery, and Cosmesis in a Neuroscience Outpatient Clinic Setting in Singapore [Editor's Choice]

    May 1, 2020, 00:00

  • The Burden of Hypoglycemia in Patients With Insulin-Treated Diabetes Mellitus in China: Analysis of Electronic Medical Records From 4 Tertiary Hospitals

    May 1, 2020, 00:00

  • Estimation of Quality-Adjusted Life Expectancy of Patients With Oral Cancer: Integration of Lifetime Survival With Repeated Quality-of-Life Measurements

    May 1, 2020, 00:00

  • Cost-Effectiveness of Transcatheter Aortic Valve Implantation Using a Balloon-Expandable Valve in Japan: Experience From the Japanese Pilot Health Technology Assessment

    May 1, 2020, 00:00

  • Association of Socioeconomic Status With Childhood Anemia Among Infant, Toddler, and Preschool Children in Bangladesh

    May 1, 2020, 00:00

  • The Development of Health Technology Assessment in Asia: Current Status and Future Trends [Editor's Choice]

    May 1, 2020, 00:00

  • Applying a Constrained Optimization Portfolio Model to Aid Prioritization of Public Health Interventions in Malaysia

    May 1, 2020, 00:00

  • Complicated Issues of Medical Examination: A Case Study of the Irkutsk Region

    May 1, 2020, 00:00

  • Table of Contents

    May 1, 2020, 00:00

  • Tackling the 3 Big Challenges Confronting Health Technology Assessment Development in Asia: A Commentary

    May 1, 2020, 00:00

  • Budget Impact Analysis of Extended-Release Phenytoin Capsules Compared With Immediate-Release Phenytoin Capsules for Patients With Epilepsy in Thailand

    May 1, 2020, 00:00

  • The Impact of Pharmaceutical Policies on Medicine Procurement Pricing in Indonesia Under the Implementation of Indonesia’s Social Health Insurance System [Editor's Choice]

    May 1, 2020, 00:00

  • The Factors Associated With Direct Medical Costs in Patients With Gastric Cancer: Quantile Regression Approach Compared With Gamma Regression

    May 1, 2020, 00:00

  • Determining the Cost and Length of Stay at Intensive Care Units and the Factors Influencing Them in a Teaching Hospital in Malaysia

    May 1, 2020, 00:00

  • Cost-Effectiveness Analysis of Xpert MTB/RIF for Multi-Outcomes of Patients With Presumptive Pulmonary Tuberculosis in Thailand [Editor's Choice]

    May 1, 2020, 00:00

  • Comparative Analysis of Prescription Drug Prices in South Asian Association for Regional Cooperation Countries

    May 1, 2020, 00:00

  • Power of 1 Malaysian Ringgit: A Low-Cost Prescription Cost-Sharing Model in Malaysia

    May 1, 2020, 00:00

  • Translation, Cultural Adaptation, and Validation of Short-Form 6D on the General Population in Indonesia

    May 1, 2020, 00:00

  • Cost-Effectiveness Analysis of Prostate-Specific Antigen Screening Among Chinese Men

    May 1, 2020, 00:00

  • The Economic Burden of Candidemia and Invasive Candidiasis: A Systematic Review

    May 1, 2020, 00:00

  • Experience of a Performance-Based Risk-Sharing Arrangement for the Treatment of Rheumatoid Arthritis With Certolizumab Pegol

    May 1, 2020, 00:00

  • Copyright/Subscription

    Dec 16, 2019, 08:54

  • In the Era of Cost-Effectiveness Analysis, Affordability Is a Limiting Factor for Patients' Access to Innovative Cancer Treatments

    Dec 1, 2019, 00:00

  • Economic Cost of Severe Acute Respiratory Infection Associated to Influenza in Colombian Children: A Single Setting Analysis

    Dec 1, 2019, 00:00

  • Inflammatory Bowel Disease in Latin America: A Systematic Review

    Dec 1, 2019, 00:00

  • Budgetary Impact of Oral Rehabilitation With Complete Dentures: An Economical Evaluation From São Paulo State, Brazil

    Dec 1, 2019, 00:00

  • Cost-Effectiveness of Proton Versus Photon Therapy in Pediatric Medulloblastoma Treatment: A Patient Volume–Based Analysis

    Dec 1, 2019, 00:00

  • The Brazilian Portuguese Version of the DISCERN Instrument: Translation Procedures and Psychometric Properties

    Dec 1, 2019, 00:00

  • Effectiveness and Cost-Effectiveness of Triple Therapy With Telaprevir and Boceprevir for Chronic Hepatitis C: A Decision Analysis From the Brazilian Public Health System Perspective

    Dec 1, 2019, 00:00

  • Resource Utilization and Costs Associated With Percutaneous Coronary Intervention When Treating Patients With Acute Coronary Syndrome in the Mexican National Institute of Cardiology “Ignacio Chávez”

    Dec 1, 2019, 00:00

  • In the Era of Cost-Effectiveness Analysis, Affordability Is a Limiting Factor for Patients' Access to Innovative Cancer Treatments

    Dec 1, 2019, 00:00

  • Burden of Disease Attributable to Obesity and Overweight in Colombia

    Dec 1, 2019, 00:00

  • Response to Letter to the Editor

    Dec 1, 2019, 00:00

  • Health Economics and Outcomes Research Knowledge Needs Assessment for Latin America [Editor's Choice]

    Dec 1, 2019, 00:00

  • A Comparison of UK and Brazilian SF-6D Preference Weights When Applied to a Brazilian Urban Population [Editor's Choice]

    Dec 1, 2019, 00:00

  • Determining the Operating Costs of a Medical Surveillance Program for Copper Miners Exposed to High Altitude–Induced Chronic Intermittent Hypoxia in Chile Using a Combination of Microcosting and Time-Driven Activity-Based Costing

    Dec 1, 2019, 00:00

  • Cost-Effectiveness of a Technology-Enhanced Diabetes Care Management Program in Mexico

    Dec 1, 2019, 00:00

  • Beneficio económico de los ensayos clínicos controlados patrocinados: El gasto evitable en medicamentos para el tratamiento de la artritis reumatoidea

    Dec 1, 2019, 00:00

  • Agnet y Judicialization en Salud en Argentina

    Dec 1, 2019, 00:00

  • The Cost-Effectiveness of Continuous Versus Intermittent Renal Replacement Therapies in Acute Kidney Injury: Perspective of the Social Services for the Elderly in Argentina

    Dec 1, 2019, 00:00

  • New Challenges in Oncology for the Brazilian Private Health Sector: Specialists' Concerns After the ISPOR International Congress in Boston, Massachusetts, 2017

    Dec 1, 2019, 00:00

  • Editorial Board

    Dec 1, 2019, 00:00

  • Cost of Patients With Hemophilia A and High-Titer Inhibitors in Colombia

    Dec 1, 2019, 00:00

  • Budget Impact of Cryoablation Versus Radiofrequency Ablation of Atrial Fibrillation in the Brazilian Public Healthcare System

    Dec 1, 2019, 00:00

  • Table of Contents

    Dec 1, 2019, 00:00

  • Cost-Effectiveness of Secukinumab Versus Other Biologics in the Treatment of Psoriatic Arthritis: An Argentinean Perspective

    Dec 1, 2019, 00:00

  • Custo-utilidade de terapias-alvo comparadas à dacarbazina para o tratamento de primeira linha do melanoma avançado não-cirúrgico e metastático no Sistema Único de Saúde do Brazil

    Dec 1, 2019, 00:00

  • Acuerdos de Riesgo Compartido: Lecciones Para su Diseño e Implementación a la Luz de la Experiencia Internacional

    Dec 1, 2019, 00:00

  • Costo de la intoxicación por Paraquat en Colombia

    Dec 1, 2019, 00:00

  • The Impact of Price Negotiations on Public Procurement Prices and Access to 8 Innovative Cancer Medicines in a Middle-Income Country: The Case of Mexico [Editor's Choice]

    Dec 1, 2019, 00:00

  • The Public Health Benefits and Economic Value of Routine Yellow Fever Vaccination in Colombia [Editor's Choice]

    Dec 1, 2019, 00:00

  • Prevalence of Symptoms and Symptom Clusters of Patients on Dialysis in Uruguay

    Dec 1, 2019, 00:00

  • Challenges in the Regulation of High-Cost Treatments: An Overview From Brazil [Editor's Choice]

    Dec 1, 2019, 00:00

  • The Price of Substitute Technologies

    Dec 1, 2019, 00:00

  • Epidemiología, consumo de recursos y costos del manejo médico de la Hepatitis C en Argentina, Colombia, Uruguay y Venezuela

    Dec 1, 2019, 00:00

  • Cost-Effectiveness of Bariatric Surgery Compared With Nonsurgical Treatment in People With Obesity and Comorbidity in Colombia

    Dec 1, 2019, 00:00

  • PRO8 PROFILAXIS EN HEMOFILIA A CON INHIBIDORES EN COLOMBIA, ¿ES POSIBLE CONTAR CON TRATAMIENTOS QUE GENEREN AHORROS AL SISTEMA DE SALUD?

    Oct 1, 2019, 00:00

  • PUK7 ANALISIS DE EFECTIVIDAD Y SEGURIDAD DE MIRABEGRON EN PACIENTES CON SINDROME DE VEJIGA HIPERACTIVA

    Oct 1, 2019, 00:00

  • EP4 HOW IS SELF-PERCEIVED HEALTH STATUS (EQ-5D) ASSOCIATED WITH SOCIOECONOMIC CONDITIONS IN 22 LATIN AMERICAN COUNTRIES?

    Oct 1, 2019, 00:00

  • PDB6 COSTO DE OBESIDAD Y SU TENDENCIA AL 2030 EN EL SISTEMA DE SALUD PUBLICO DEL PERU

    Oct 1, 2019, 00:00

  • PSY4 BURDEN OF DISEASE FOR RHEUMATOID ARTHRITIS IN COLOMBIA AND BRAZIL

    Oct 1, 2019, 00:00

  • PCN44 DESIGUALDADES EN EL DIAGNÓSTICO DE CÁNCER DE CÉRVIX EN LAS REGIONES DE COLOMBIA

    Oct 1, 2019, 00:00

  • PDG9 EVALUACIÓN PARA LA SELECCIÓN DE PRECIO MÁXIMO DE VENTA DE MEDICAMENTOS

    Oct 1, 2019, 00:00

  • PIN8 ANALISE ECONOMICA DE CUSTOS DE TRATAMENTO DE INFECCOES POR MICROORGANISMOS GRAM-POSITIVOS RESISTENTES: STAPHYLOCOCCUS AUREUS RESISTENTE A METICILINA (MRSA) E ENTEROCOCCUS SPP RESISTENTES A VANCOMICINA (VRE)

    Oct 1, 2019, 00:00

  • PCN41 IMPACT OF DISEASE RELATED GROUP IN BREAST CANCER TREATMENT IN THE BRAZILIAN PUBLIC HEALTHCARE SYSTEM

    Oct 1, 2019, 00:00

  • PNS59 IMPACTO DEL MODELO DE RIESGO COMPARTIDO EN LA TASA DE EVENTOS HOSPITALARIOS DE UN SEGURO VOLUNTARIO EN COLOMBIA

    Oct 1, 2019, 00:00

  • PCN29 TENDENCIAS EN LA MORTALIDAD DEL CANCER DE MAMA EN COLOMBIA EN MUJERES MAYORES DE 60 AÑOS

    Oct 1, 2019, 00:00

  • PMU14 USO DEL EQ-5D EN MEXICO

    Oct 1, 2019, 00:00

  • PDB4 COST-EFFECTIVENESS ANALYSIS OF SWITCHING FROM ALOGLIPTIN TO VILDAGLIPTIN IN THE TREATMENT OF TYPE 2 DIABETES

    Oct 1, 2019, 00:00

  • PRO14 COMPARAR A INCIDÊNCIA DE COMORBIDADES NO TRATAMENTOS DE MIELOMA MÚLTIPLO ENTRE AS TERAPIAS DO SISTEMA DE SAÚDE BRASILEIRO (SUS) COM AS AINDA NÃO INCORPORADAS

    Oct 1, 2019, 00:00

  • PIT7 THE PROFILE OF FIREARMS INJURIES IN BRAZIL BETWEEN 2009 AND 2016

    Oct 1, 2019, 00:00

  • PIN11 COST-EFFECTIVENESS OF INTERFERON-GAMMA RELEASE ASSAY COMPARED TO TUBERCULIN SKIN TEST FOR DETECTION OF LATENT TUBERCULOSIS IN PATIENTS WITH RENAL FAILURE UNDERGOING HEMODIALYSIS

    Oct 1, 2019, 00:00

  • PIN3 COSTS AND CONSEQUENCES OF CEFTAROLINE FOSAMIL FOR THE TREATMENT OF COMPLICATED SKIN AND SOFT TISSUE INFECTIONS (CSSTI) IN BRAZILIAN PRIVATE HEALTHCARE SYSTEM

    Oct 1, 2019, 00:00

  • PND12 WORK PRODUCTIVITY AND DAILY ACTIVITIES IMPAIRMENT (WPAI) IN CHILEAN PATIENTS WITH MIGRAINE: PERSPECTIVES ON INDIRECT-COSTS DRIVERS

    Oct 1, 2019, 00:00

  • PDB1 CALIDAD DE VIDA ASOCIADA CON OBESIDAD EN PACIENTES MEXICANOS

    Oct 1, 2019, 00:00

  • PSY8 CURRENT PRACTICE AND RESOURCE USE ASSOCIATED WITH TREATMENT OF VENOUS THROMBOEMBOLISM DISEASE IN SOCIAL SECURITY SECTOR OF ARGENTINA

    Oct 1, 2019, 00:00

  • PDG11 IMPLEMENTATION OF INDICATORS IN THE PROCESS OF ACQUISITION OF MEDICINES IN THE HOSPITAL UNITS OF THE STATE SECRETARIAT OF HEALTH OF SANTA CATARINA: THE USE OF THE ECONOMIC RATIO INDEX

    Oct 1, 2019, 00:00

  • PIH8 MODEL TO APPROACH TO THE ECONOMIC BURDEN OF UNPLANNED PREGNANCY IN CHILE: THE IMPACT OF THE FAILURE OF COMPLIANCE OF THE CONTRACEPTIVE METHODS.

    Oct 1, 2019, 00:00

  • PNS23 EPIDEMIOLOGY OF MYELOPROLIFERATIVE DISORDERS: REAL WORLD DATA STUDY IN BRAZIL

    Oct 1, 2019, 00:00

  • PMD12 HOW MUCH CAN COLOMBIAN HOSPITALS EARN FOR EACH THERAPEUTIC PLASMA EXCHANGE (TPE) PROCEDURE? A MULTI-CENTER, COST COMPARISON STUDY BETWEEN CENTRIFUGAL AND MEMBRANE SYSTEMS

    Oct 1, 2019, 00:00

  • PCV9 IMPACTO CLINICO Y ECONOMICO DE LAS ENFERMEDADES CARDIOVASCULARES (ECV) EN LA POBLACION ADULTA DENTRO DEL SISTEMA DE SALUD DE MEXICO.

    Oct 1, 2019, 00:00

  • PNS7 THE PRICE OF SUBSTITUTE TECHNOLOGIES

    Oct 1, 2019, 00:00

  • PRS4 HEALTH TECHNOLOGY ASSESSMENT OF DUPILUMAB IN SEVERE BRONCHIAL ASTHMA IN THE RUSSIAN FEDERATION

    Oct 1, 2019, 00:00

  • PDB11 BUDGET IMPACT ANALYSIS OF SWITCHING FROM ALOGLIPTIN TO VILDAGLIPTIN IN THE TREATMENT OF TYPE 2 DIABETES

    Oct 1, 2019, 00:00

  • PNS29 CHANGING OF HEALTH CARE TOURISM AND ITS RECOVERING ROLE FOR ECONOMY

    Oct 1, 2019, 00:00

  • PNS3 BRAZILIAN PHARMACEUTICAL INDUSTRY: THE IMPACT OF PUBLIC POLICIES AIMED AT FOSTERING LOCAL MANUFACTURING

    Oct 1, 2019, 00:00

  • PNS35 THE EFFECT OF FINANCIAL INCENTIVE ON RETAINING DENTISTS IN RURAL AREAS IN THAILAND

    Oct 1, 2019, 00:00

  • PIN9 PUBLIC HEALTH AND ECONOMIC IMPACT OF A GENDER-NEUTRAL QUADRIVALENT HUMAN PAPILLOMAVIRUS VACCINATION PROGRAM IN COLOMBIA

    Oct 1, 2019, 00:00

  • PCN17 COSTO-EFECTIVIDAD DE AFATINIB COMO PRIMERA LÍNEA EN EL TRATAMIENTO DEL CÁNCER DE PULMÓN DE CÉLULAS NO PEQUEÑAS AVANZADO CON MUTACIÓN POSITIVA DEL RECEPTOR DEL FACTOR DE CRECIMIENTO EPIDÉRMICO EN COLOMBIA

    Oct 1, 2019, 00:00

  • PCN39 ACCESS TO MEDICAL INTERVENTIONS IN BRAZIL: THE ROLE OF CLINICAL RESEARCH AND OF HEALTH JUDICIALIZATION

    Oct 1, 2019, 00:00

  • PCN62 PRELIMIANARY ANALYSIS OF TIROSINE KINASE INHIBITOR THERAPY IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA A FIVE YEARS FOLLOW-UP FROM A REAL WORLD COHORT

    Oct 1, 2019, 00:00

  • PMS5 USE OF AN ALGORITHM WITHIN A MULTIDISCIPLINARY CONSULTATION FOR THE MANAGEMENT OF PATIENTS WITH RHEUMATOID ARTHRITIS CANDIDATES FOR BIOLOGICAL THERAPY - A STRATEGY FOR OPTIMIZING COSTS

    Oct 1, 2019, 00:00

  • PNS46 ATENCION VIRTUAL EN SALUD: DE LA ESTRATEGIA A LA TACTICA

    Oct 1, 2019, 00:00

  • HI4 ADHERENCE TO TREATMENT IS ASSOCIATED WITH GOOD CLINICAL RESULTS IN PATIENTS TREATED WITH BIOLOGICAL THERAPY IN A CENTER OF EXCELLENCE IN RHEUMATOID ARTHRITIS

    Oct 1, 2019, 00:00

  • PND5 COST-EFFECTIVENESS OF MECHANICAL THROMBECTOMY USING SOLITAIRE STENT RETRIEVER IN COMBINATION WITH INTRAVENOUS TISSUE PLASMINOGEN ACTIVATOR (IV-TPA) VERSUS IV-TPA ALONE FOR THE TREATMENT OF ACUTE ISCHAEMIC STROKE DUE TO LARGE VESSEL OCC ...

    Oct 1, 2019, 00:00

  • PMS18 COST-ANALYSIS OF TREATMENT FOR MODERATE AND SEVERE RHEUMATOID ARTHRITIS IN A SPECIALIZED RHEUMATOLOGY CENTER

    Oct 1, 2019, 00:00

  • PDG16 ACESSO A INFORMAÇÕES E SERVIÇOS PRESTADOS PELA SUPERINTENDÊNCIA DE ASSISTÊNCIA FARMACÊUTICA DO ESTADO DE MINAS GERAIS POR MEIO DO APLICATIVO MGAPP

    Oct 1, 2019, 00:00

  • PDB10 COST-EFFECTIVENESS ANALYSIS OF CONTINUOUS SUBCUTANEOUS INSULIN INFUSION IN TYPE 1 DIABETES MELLITUS COMPARED WITH MULTIPLE DAILY INJECTIONS IN THE RUSSIAN FEDERATION

    Oct 1, 2019, 00:00

  • PNS2 COLOMBIA'S HEALTHCARE REFORM: COST-CONTAINMENT MECHANISMS AND IMPLICATIONS FOR SUSTAINABILITY

    Oct 1, 2019, 00:00

  • PCN37 FDA NEW DRUGS APPROVAL FOR BREAST, COLORECTAL, PROSTATE AND LUNG CANCER AND HORIZON SCANNING OPPORTUNITY

    Oct 1, 2019, 00:00

  • PIH15 CURRENT PANORAMA OF THE SURGICAL TREATMENT OF ENDOMETRIOSIS BY THE BRAZILIAN PUBLIC SYSTEM

    Oct 1, 2019, 00:00

  • PDG1 POLIMIXINA B: EXISTEM FATORES DE RISCO ASSOCIADOS À NEFROTOXICIDADE EM PACIENTES QUE UTILIZARAM ESTE MEDICAMENTO?

    Oct 1, 2019, 00:00

  • PSU7 COST-EFFECTIVENESS ANALYSIS OF APIXABAN FOR THE PREVENTION OF VENOUS THROMBOEMBOLIC EVENTS AFTER HIP OR KNEE REPLACEMENT SURGERY IN COLOMBIA

    Oct 1, 2019, 00:00

  • PDB3 PHARMACIST LED INTERVENTION ON HEALTH-RELATED QUALITY OF LIFE OF DIABETIC PATIENTS AND ITS RELATIONSHIP WITH PATIENT DEMOGRAPHICS ON EQ-5D DOMAINS AND VAS SCORE

    Oct 1, 2019, 00:00

  • PNS31 A VIA ADMINISTRATIVA COMO UMA ALTERNATIVA DE ACESSO AO MEDICAMENTO NO SISTEMA ÚNICO DE SAÚDE: SOLUÇÃO OU PROBLEMA?

    Oct 1, 2019, 00:00

  • PCN30 REAL-WORLD DATA FOR COSTS RELATED TO CANCER MANAGEMENT IN BRAZIL: AN OVERVIEW OF THE LITERATURE

    Oct 1, 2019, 00:00

  • PMH1 COST-OF-ILLNESS STUDIES FOR DEPRESSION AND BIPOLAR DISORDER IN LATIN AMERICA: A SYSTEMATIC REVIEW

    Oct 1, 2019, 00:00

  • PRO13 IMPACT OF CAREGIVER EXPERIENCE AND HRQOL IN LATER-ONSET SPINAL MUSCULAR ATROPHY (SMA): RESULTS FROM THE PHASE 3 CHERISH TRIAL

    Oct 1, 2019, 00:00

  • PRS8 HEALTH RESOURCE USE OF COPD PATIENTS IN THE BRAZILIAN PRIVATE HEALTHCARE SETTING

    Oct 1, 2019, 00:00

  • PIN23 EVALUACIÓN DE LAS PROPIEDADES PSICOMÉTRICAS DEL EQ-5D-5L EN PACIENTES CON VIH/SIDA EN COLOMBIA

    Oct 1, 2019, 00:00

  • PNS14 EVIDENCE ON THE POSTPONEMENT OF MATERNITY IN BRAZIL

    Oct 1, 2019, 00:00

  • PMS11 EPIDEMIOLOGY, USE OF RESOURCES AND COST OF MODERATE TO SEVERE RHEUMATOID ARTHRITIS IN ARGENTINA: AN EXTENSIVE REVIEW WITH EXPERT ELICITATION

    Oct 1, 2019, 00:00

  • PNS54 AUDITORIA SOCIAL COMO FERRAMENTA DE ANALISE DA QUALIDADE DO ATENDIMENTO NA SAUDE

    Oct 1, 2019, 00:00

  • MT4 ANALISIS DE IMPACTO PRESUPUESTARIO SOBRE LA INCORPORACION DEL COCIENTE SFLT-1/PLGF PARA PREDECIR EL RIESGO DE PREECLAMPSIA EN LA COBERTURA DE LAS OBRAS SOCIALES NACIONALES DE ARGENTINA

    Oct 1, 2019, 00:00

  • CN2 EVALUACIÓN DE COSTO-EFECTIVIDAD DE LA ENZALUTAMIDA (ENZA) FRENTE A LA ABIRATERONA (ABI) PARA EL TRATAMIENTO DE PACIENTES CON CÁNCER DE PRÓSTATA RESISTENTE A LA CASTRACIÓN METASTÁSICO (CPRCM) ANTES DEL USO DE DOCETAXEL EN EL INSTITUTO ME ...

    Oct 1, 2019, 00:00

  • PNS44 COORDENAÇÃO DE CUIDADOS DE SAÚDE ATRAVÉS DE UM APLICATIVO MÓVEL COMO FATOR DE MELHOR RESULTADO CLÍNICO E REDUÇÃO DE CUSTOS

    Oct 1, 2019, 00:00

  • PDG8 COST-EFFECTIVENESS ANALYSIS OF MIDOSTAURIN (MIDO) + INTENSIVE CHEMOTHERAPY (SOC) FOR THE TREATMENT OF ACUTE MYELOID LEUKEMIA IN ADULTS WITH FLT3 MUTATION IN COLOMBIA

    Oct 1, 2019, 00:00

  • PND9 BUDGET IMPACT ANALYSIS OF CLADRIBINE COMPARED TO THE CURRENT COVERAGE SCHEME IN CHILE TO TREAT PATIENTS WITH HIGHLY ACTIVE RELAPSING REMITTING MULTIPLE SCLEROSIS

    Oct 1, 2019, 00:00

  • PMU11 COMPARATIVE ASSESSMENT OF HTA OUTCOMES IN BRAZIL, CANADA AND THE UNITED KINGDOM

    Oct 1, 2019, 00:00

  • PCN1 EFECTIVIDAD Y SEGURIDAD DEL ESQUEMA DABRAFENIB-TRAMETINIB EN EL TRATAMIENTO DEL MELANOMA AVANZADO/METASTÁSICO IRRESECABLE CON MUTACIÓN BRAF V600: REVISIÓN SISTEMÁTICA DE LA LITERATURA Y METANÁLISIS EN RED

    Oct 1, 2019, 00:00

  • PMU7 POPULATION HEALTH IMPACT MODEL

    Oct 1, 2019, 00:00

  • PDB9 ESTUDIO DE COSTOS DE LA HIPOGLICEMIA EN PACIENTES CON DIABETES MELLITUS TIPO 2 DESDE LA PERSPECTIVA DE SALUD PUBLICA DE CHILE

    Oct 1, 2019, 00:00

  • PMU8 DIFERENCIAS EN LA MORTALIDAD SEGUN LUGAR DE OCURRENCIA Y REGIMEN DE SALUD EN EL CARIBE COLOMBIANO, 2016

    Oct 1, 2019, 00:00

  • PCV4 ANNUAL HEALTH INSURANCE TREATMENT COST OF HYPERTENSIVE RENAL DISEASE IN HUNGARY: COST OF ILLNESS STUDY BASED ON REAL WORLD DATA

    Oct 1, 2019, 00:00

  • PIT6 SELF-INFLICTED LESIONS IN BRAZIL: A DESCRIPTIVE ANALYSIS BETWEEN 2009 AND 2016

    Oct 1, 2019, 00:00

  • PUK4 FACTORES ASOCIADOS DE LA PROGRESION DE LA ENFERMEDAD RENAL CRONICA EN UN PROGRAMA DE INTERVENCION DEL RIESGO CARDIOVASCULAR DEL CARIBE COLOMBIANO

    Oct 1, 2019, 00:00

  • PMD4 ANALISIS DE IMPACTO PRESUPUESTARIO SOBRE LA INCORPORACION DEL COCIENTE SFLT-1/PLGF PARA PREDECIR EL RIESGO DE PREECLAMPSIA EN EL SISTEMA DE SALUD PUBLICO DE MENDOZA, ARGENTINA

    Oct 1, 2019, 00:00

  • CV4 EVALUACION DE LOS MOTIVOS DE LA OMISION DE RETIROS DE MEDICAMENTOS PENDIENTES EN LA OFICINA DE FARMACIA. POSIBLES SOLUCIONES

    Oct 1, 2019, 00:00

  • PCV15 GOOD PRACTICES ASSESSMENT FOR CARDIAC SURGERIES: A REAL WORLD ANALYSIS

    Oct 1, 2019, 00:00

  • PMS4 MEDICATION PATTERNS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS - CHARACTERISTICS AND COSTS OF THERAPY

    Oct 1, 2019, 00:00

  • PRS2 COST ANALYSIS FOR THE TREATMENT OF SEVERE UNCONTROLLED BRONCHIAL ASTHMA IN THE RUSSIAN FEDERATION

    Oct 1, 2019, 00:00

  • PMS3 PSYCHOLOGY CONSULTATION FOR PATIENTS WITH RHEUMATOID ARTHRITIS - A LOW-COST INTERVENTION WITH GREAT BENEFITS

    Oct 1, 2019, 00:00

  • PRO4 COST-EFFECTIVENESS ANALYSIS OF AN INTEGRATED EXTRACORPOREAL PHOTOPHERESIS SYSTEM VERSUS SELECTED TREATMENTS FOR REFRACTORY CHRONIC GRAFT VERSUS HOST DISEASE

    Oct 1, 2019, 00:00

  • PCV14 IMPACTO DE LA INTERVENCION FARMACEUTICA (IF) EN LA NO ADHERENCIA A TRATAMIENTOS POR OMISION DE RETIRO DE MEDICAMENTOS FINANCIADOS

    Oct 1, 2019, 00:00

  • PCN18 ANTINEOPLASICOS ORAIS NA PRIMEIRA LINHA DE TRATAMENTO DE LEUCEMIA MIELOIDE CRONICA: UMA ANALISE DE CUSTO

    Oct 1, 2019, 00:00

  • TP4 REAL-WORLD PATIENT CHARACTERISTICS AND OUTCOMES OF RESECTED STAGE III MELANOMA PATIENTS IN ARGENTINA AND BRAZIL

    Oct 1, 2019, 00:00

  • CM4 TIME TO TREATMENT EFFECT, EVENT-FREE SURVIVAL, AND MOTOR MILESTONE ACHIEVEMENT IN TYPE I SPINAL MUSCULAR ATROPHY PATIENTS TREATED WITH ONASEMNOGENE ABEPARVOVEC (AVXS-101) OR NUSINERSEN CONTRASTED TO NATURAL HISTORY

    Oct 1, 2019, 00:00

  • PDB2 SELF-MONITORING OF BLOOD GLUCOSE (SMBG) LEVELS IN SELECTED LATIN AMERICAN COUNTRIES — HOW DOES IT MEASURE UP TO MAJOR GLUCOSE MONITORING GUIDELINES?

    Oct 1, 2019, 00:00

  • PGI1 EFFECTS OF FECAL MICROBIOTA TRANSPLANTATION IN INFLAMMATORY BOWEL DISEASE PATIENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS

    Oct 1, 2019, 00:00

  • CN4 ANÁLISIS DE COSTO-UTILIDAD E IMPACTO PRESUPUESTARIO DE LA ENZALUTAMIDA PARA EL TRATAMIENTO DEL CÁNCER DE PRÓSTATA RESISTENTE A LA CASTRACIÓN NO METASTÁSICO (CPRCNM) EN ARGENTINA

    Oct 1, 2019, 00:00

  • PNS52 EQ-5D-5L SOCIAL VALUES IN PERU: A NOVEL "LITE” APPROACH

    Oct 1, 2019, 00:00

  • PIH11 ESTIMACION DE LA VARIACION DE COSTOS PRIVADOS E INSTITUCIONALES DE TRATAMIENTO DE LA DISMENORREA PRIMARIA EN MUJERES MEXICANAS.

    Oct 1, 2019, 00:00

  • PGI5 BURDEN OF LIVER DISEASE, COLOMBIA 2009-2016

    Oct 1, 2019, 00:00

  • EP2 PUBLIC HEALTH AND ECONOMIC IMPACT OF A QUADRIVALENT HUMAN PAPILLOMAVIRUS VACCINATION PROGRAM FOR FEMALES AGED 9 YEARS IN EL SALVADOR

    Oct 1, 2019, 00:00

  • PND4 ANALISIS DE MINIMIZACION DE COSTOS DE TOPIRAMATO DE LIBERACION PROLONGADA PARA LA PREVENCION DE MIGRAÑA EN ADULTOS Y ADOLESCENTES A PARTIR DE LOS 12 AÑOS

    Oct 1, 2019, 00:00

  • PIN2 SISTEMA ELETRONICO INTEGRADO NO GERENCIAMENTO DO PROGRAMA STEWARDSHIP NUMA OPERADORA DE PLANOS DE SAUDE

    Oct 1, 2019, 00:00

  • PDG12 EXPERIENCIA INTERNACIONAL EN VALOR TERAPÉUTICO Y PRECIO BASADO EN VALOR. REVISIÓN RÁPIDA DE LA LITERATURA

    Oct 1, 2019, 00:00

  • PMS13 A ROUTE FOR THE CORRECT DIAGNOSIS OF RHEUMATOID ARTHRITIS - AN OPPORTUNITY TO AVOID MISDIAGNOSIS AND COSTS ASSOCIATED

    Oct 1, 2019, 00:00

  • PIN27 USO DE LA REGRESIÓN BETA EN EL ANALISIS DE ASOCIACIÓN ENTRE LOS ÍNDICES EQ-5D-5L, EQ-EVA Y POTENCIALES COVARIABLES EN PACIENTES CON VIH/SIDA EN COLOMBIA

    Oct 1, 2019, 00:00

  • PUK3 COST CONSEQUENCE ANALYSIS OF A REMOTE PATIENT MONITORING PROGRAM TO IMPROVE CLINICAL PRACTICE OF AUTOMATED PERITONEAL DYALISIS IN BRAZIL

    Oct 1, 2019, 00:00

  • PNS47 ANÁLISIS PARA LA IMPLEMENTACIÓN DE NUEVOS MODELOS DE ACCESO PARA EL SISTEMA NACIONAL DE SALUD DEL ECUADOR

    Oct 1, 2019, 00:00

  • PCN14 COSTOS INDIRECTOS DEL CANCER DE MAMA EN COLOMBIA: 1990-2016.

    Oct 1, 2019, 00:00

  • PMS10 NATIONWIDE ANNUAL HEALTH INSURANCE TREATMENT COST OF JUVENILE AND ADOLESCENT IDIOPATHIC SCOLIOSIS IN HUNGARY: COST OF ILLNESS STUDY BASED ON REAL WORLD DATA

    Oct 1, 2019, 00:00

  • PNS41 VALUE BASED HEALTH CARE (CUIDADO BASADO EM VALOR) EN AMERICA LATINA: RESULTADOS PRELIMINARES DE UNA INVESTIGACION CON 40 HOSPITALES DE CINCO PAISES LATINOAMERICANOS

    Oct 1, 2019, 00:00

  • HI1 PRELIMINARY COST ANALYSIS OF MISDIAGNOSIS OF RHEUMATOID ARTHRITIS

    Oct 1, 2019, 00:00

  • PNS22 DESCRIBING GAPS IN ACCESS TO HEALTHCARE BETWEEN INTERNATIONAL MIGRANTS AND THE CHILEAN-BORN POPULATION

    Oct 1, 2019, 00:00

  • MT2 REMOTE MONITORING COMPARED TO CONVENTIONAL FOLLOW-UP FOR PATIENTS WITH HEART FAILURE USING IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR: A BUDGET IMPACT ANALYSIS

    Oct 1, 2019, 00:00

  • PAM1 RESULTADOS DE LA IMPLEMENTACION DEL MODELO DE SOPORTE NUTRICIONAL EN LOS NIVELES HOSPITALARIO Y DOMICILIARIO

    Oct 1, 2019, 00:00

  • PIH2 COST-EFFECTIVENESS ANALYSIS OF MEDICINES FOR CONTROLLED OVARIAN STIMULATION IN THE TREATMENT OF INFERTILITY IN PATIENTS WITH AN SUBOPTIMAL OVARIAN RESPONSE IN THE RUSSIAN FEDERATION

    Oct 1, 2019, 00:00

  • PMU10 RESULTADOS DE IMPLEMENTACION DE PROGRAMA DE CUIDADOS PALIATIVOS EN UNA ASEGURADORA EN SALUD EN COLOMBIA

    Oct 1, 2019, 00:00

  • PMS8 CONVENTIONAL VERSUS BIOLOGICAL TREATMENT FOR ANKYLOSING SPONDYLITIS. RESULTS FROM A REAL-LIFE SETTING

    Oct 1, 2019, 00:00

  • PBI6 EVALUATION OF BIOLOGIC THERAPIES FOR THE TREATMENT OF MODERATE-TO-SEVERE PLAQUE PSORIASIS IN COLOMBIA: A COST PER RESPONDER ANALYSIS (CPR)

    Oct 1, 2019, 00:00

  • PCV2 TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) IN ARGENTINA: META-ANALYSIS OF REAL-LIFE DATA

    Oct 1, 2019, 00:00

  • PRO3 DIRECT COSTS OF HEMOPHILIA CARE, THE CASE OF A HEALTH INSURER IN COLOMBIA

    Oct 1, 2019, 00:00

  • PMH10 TREATMENT-RESISTANT DEPRESSION IN LATIN AMERICA: PRELIMINARY RESULTS FROM THE TRAL STUDY

    Oct 1, 2019, 00:00

  • PSY10 COST-EFFECTIVENESS ANALYSIS OF DRUG CHALLENGE TEST COMPARED TO SPECIFIC IGE DOSAGE FOR THE DIAGNOSIS OF PATIENTS WITH SUSPECT OF PENICILLIN ALLERGY

    Oct 1, 2019, 00:00

  • PAM2 GESTION DE SOPORTE NUTRICIONAL EN CUIDADOS INTENSIVOS

    Oct 1, 2019, 00:00

  • PNS12 THE IMPACT OF THE POSTPONEMENT OF MATERNITY ON WOMEN'S INCOME IN BRAZIL

    Oct 1, 2019, 00:00

  • PIN4 A BUDGET IMPACTO ANALYSIS OF TENOFOVIR ALAFENAMIDE/EMTRICITABINE (DESCOVY®) FOR THE TREATMENT OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (HIV-1) INFECTION IN PATIENTS AGED 12 YEARS AND OLDER, IN MEXICO

    Oct 1, 2019, 00:00

  • PMS12 BENEFICIOS CLINICOS Y ECONOMICOS EN LA IMPLEMENTACION DE UNIDADES DE COORDINACION DE FRACTURAS (FLS) EN MEXICO

    Oct 1, 2019, 00:00

  • PAM6 COMPLEMENTARY AND INTEGRATIVE THERAPIES IN BRAZIL'S UNIFIED HEALTHCARE SYSTEM (SUS) IN 2017: AN UNDERREPORTING CASE

    Oct 1, 2019, 00:00

  • PCN16 COST ESTIMATE ANALYSIS OF ABIRATERONE PLUS PREDNISONE (AAP) AND ENZALUTAMIDE (ENZ) IN INSURED METASTATIC CASTRATION RESISTANT PROSTATE CANCER PATIENTS IN ARGENTINA: EVIREPRO DATABASE

    Oct 1, 2019, 00:00

  • PSU4 BUDGET IMPACT ANALYSIS OF TRICLOSAN-COATED SUTURES FOR SURGICAL SITE INFECTION PREVENTION IN COLOMBIA

    Oct 1, 2019, 00:00

  • PCN40 COSTS OF COMPREHENSIVE CARE OF HEPATOCELLULAR CARCINOMA IN A MODEL PUBLIC PROVIDER IN CHILE: IS IT POSSIBLE TO PROMOTE FINANCIAL COVERAGE?

    Oct 1, 2019, 00:00

  • PSY6 HUMANISTIC AND ECONOMIC BURDEN OF DISEASE FOR PSORIASIS IN ARGENTINA, BRAZIL, COLOMBIA AND MEXICO

    Oct 1, 2019, 00:00

  • PNS20 REPORTS OF SUBSTANDARD MEDICINES: AN ANALYSIS OF THE BRAZILIAN HEALTH SURVEILLANCE NOTIFICATION SYSTEM

    Oct 1, 2019, 00:00

  • EP1 SCHOOL ENVIRONMENT FACTORS ASSOCIATED WITH ADOLESCENTS BMI IN BRAZIL

    Oct 1, 2019, 00:00

  • PIH14 BURDEN OF PNEUMOCOCCAL DISEASE HOSPITALIZATIONS IN OLDER ADULTS 60Y+ IN FIVE CAPITALS IN BRAZIL

    Oct 1, 2019, 00:00

  • PBI11 ESTUDIOS DE SINTESIS Y TOMA DE DECISIONES: A PROPOSITO DE LA CONTINUACION DEL TRATAMIENTO CON UN BIOSIMILAR EN PACIENTES QUE RECIBEN INFLIXIMAB EN EL SEGURO SOCIAL EN SALUD EN PERU

    Oct 1, 2019, 00:00

  • PND14 OUT-OF-POCKET EXPENDITURE IN MIGRAINE PATIENTS WITH AND WITHOUT COMORBIDITIES IN CHILE: A HEALTHCARE SYSTEM PERSPECTIVE

    Oct 1, 2019, 00:00

  • CL3 ESTUDIO DE EVALUACIÃN ECONÃMICA DEL APÃSITO TRANSPARENTE IMPREGNADO CON CLORHEXIDINA, PARA LA FIJACIÃN DE CATÃTERES CENTRALES BAJO EL CONTEXTO DE LOS HOSPITALES PÃBLICOS DE REPáBLICA DOMINICANA: CASO HOSPITAL DOCENTE PADRE BILLINI, AÃO ...

    Oct 1, 2019, 00:00

  • PNS19 AN ANALYSIS OF CONTINUED CASH BENEFIT: PERSONS WITH DISABILITIES OVER 16 YEARS OLD

    Oct 1, 2019, 00:00

  • PNS50 ANALISIS DE IMPACTO DE LA IMPLEMENTACION DE UNA RED INTEGRADA MEDIANTE LA MEDIDA DE CALIDAD DE VIDA RELACIONADA CON LA SALUD EN POBLACION COLOMBIANA

    Oct 1, 2019, 00:00

  • PCN33 PERTUZUMAB+TRASTUZUMAB TREATMENT ON HER2+ EARLY BREAST CANCER: LONG-TERM REDUCTION OF METASTASIC BREAST CANCER INCIDENCE IN ARGENTINA.

    Oct 1, 2019, 00:00

  • PIH6 APPROACH TO THE IMPACT OF COVERAGE IN LONG-TERM CONTRACEPTION IN THE ECONOMIC BURDEN OF UNPLANNED PREGNANCY FROM THE PERSPECTIVE OF ISAPRES IN CHILE

    Oct 1, 2019, 00:00

  • PIH23 SISTEMATIZACION DE EXPERIENCIAS EN EL DESARROLLO DE UNA ESTRATEGIA NO CONVENCIONAL PARA EDUCAR EN SALUD A GESTANTES DEL PROGRAMA SER MADRE-HIJO DE MUTUAL SER EPS.

    Oct 1, 2019, 00:00

  • PMD8 COST-EFFECTIVENESS OF THERMOABLATION VERSUS SURGERY FOR TREATMENT OF LIVER METASTASIS

    Oct 1, 2019, 00:00

  • PSU5 ANALISIS COSTE CONSECUENCIA DEL TRASPLANTE DE PROGENITORES HEMATOPOYETICOS DE DONANTE NO RELACIONADO FINANCIADO POR EL FONDO INTANGIBLE SOLIDARIO DE SALUD DEL PERU

    Oct 1, 2019, 00:00

  • PNS24 GASTOS COM MEDICAMENTOS E SEU IMPACTO NA RENDA DAS FAMÍLIAS BRASILEIRAS

    Oct 1, 2019, 00:00

  • PNS17 SELF-PERCEIVED DISCRIMINATION AMONG INTERNATIONAL MIGRANTS IN CHILE: RESULTS FROM A NATIONAL-BASED SURVEY (CASEN) 2017

    Oct 1, 2019, 00:00

  • PMD13 BUNDLE AND RISK SHARING FOR BARIATRIC SURGERY UNDER THE VALUE-BASED CARE (VBC) MODEL: MODEL EFFECTIVENESS AND SUSTAINABILITY AT HOSPITAL ALEMAO OSWALDO CRUZ (HAOC) BASED IN CLINICAL AND ECONOMICAL RESULTS

    Oct 1, 2019, 00:00

  • PIN15 PUBLIC HEALTH IMPACT OF DENGUE VACCINATION WITH SCREENING IN BRAZIL

    Oct 1, 2019, 00:00

  • PCN3 BRAND-BRAND ONCOLOGY COMBINATIONS: HURDLES AND IMPLICATIONS

    Oct 1, 2019, 00:00

  • PCN67 ANALYSIS OF TREATMENT PATTERNS FOR PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER IN THE BRAZILIAN SUPPLEMENTARY HEALTHCARE SYSTEM IN DIFFERENT GEOGRAPHIC REGIONS OF BRAZIL

    Oct 1, 2019, 00:00
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8 (current)
  • 9
  • 10
  • »